OOIR: Observatory of International Research

Papers

(The H4-Index of Osteoporosis International is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Hypercalcemia in non-Hodgkin’s lymphoma due to cosecretion of PTHrP and 1,25-dihydroxyvitamin D	605
Comment on “Rebound hypercalcemia post-denosumab cessation in metastatic breast cancer”: Waxing-Waning Serum Calcium following Denosumab use in a patient with Polyostotic Paget’s Disease of Bone	202
Letter to the editor regarding “Opportunistic Use of Lumbar Magnetic Resonance Imaging for Osteoporosis Screening”	77
RE: “Race/ethnic differences in trabecular bone score in mid-life women: the Study of Women’s Health Across the Nation (SWAN)”	76
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Oral Communication Abstracts	76
World Congress on Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Author Index	69
The association between blood cadmium levels and bone mineral density in U.S. adolescents aged 12–19 years	67
The clinical trial landscape of anti-RANKL agents for osteoporosis: current status and future directions	67
Trends in screening and treatment of osteoporosis after periprosthetic fractures from 2010 to 2020	50
Epidemiology of osteoporotic ankle fractures in South Korea: a nationwide retrospective cohort study (2006–2022)	49
Cost-effectiveness intervention thresholds for romosozumab and teriparatide in the treatment of osteoporosis in the UK	48
Tea consumption and the risks of osteoporosis and hip fracture: a population-based longitudinal follow-up study	47
Sarcopenia, osteoporosis, and fractures: what we see mainly depends on how we look?	47
Bridging the gap: enhancing osteoporosis management through AI-driven predictive models	45
Scaffolds: a biomaterial engineering in targeted drug delivery for osteoporosis	45
Identifying rare variants in genes related to bone phenotypes in a cohort of postmenopausal women	41
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): ROS-IOF-ESCEO Symposium Abstracts	40
Comparison of the efficacy between sequential therapy with teriparatide and denosumab and denosumab monotherapy in suppressing fragility fracture risk	39
Return on investment of fracture liaison services: a systematic review and analysis	36
COVID pandemic and denosumab adherence	34
Trends in incidence, health care consumption, and costs for proximal femoral fractures in the Netherlands between 2000 and 2019: a nationwide study	33
Reply to comments on “Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis”	32
Cost-effectiveness of 3 versus 6 years of zoledronic acid treatment before bisphosphonate holiday for women with osteoporosis	32
Vertebral fracture severity assessment on anteroposterior radiographs with a new semi-quantitative technique	31
Cross-sectional associations between adipose tissue depots and areal bone mineral density in the UK Biobank imaging study	31

The cumulative incidence of and risk factors for morphometric severe vertebral fractures in Japanese men and women: the ROAD study third and fourth surveys	30
FRAX-based intervention thresholds for Pakistan	30
The effects of β-carotene on osteoporosis: a systematic review and meta-analysis of observational studies	29
Effects of intermittent or single high-dose vitamin D supplementation on risk of falls and fractures: a systematic review and meta-analysis	29
The use of oral glucocorticoids and the risk of major osteoporotic fracture in patients with myasthenia gravis	29